2m 2m 2m 2m 2m 2m 2m
CYTOMED THERA (GDTC)
NASDAQ
$0.87-$0.16 (-15.24%)
Price as of Aug 21, 2026 7:58 PM EDT- $11.3MMarket Cap
- -44.29%1-Year Change
- BiotechnologyIndustry
CYTOMED THERA (GDTC)
$0.87-$0.16 (-15.24%)
GDTC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.03 | ||
Change | +$0.13 (+14.57%) | ||
Open | $0.80 | ||
High | $1.03 | ||
Low | $0.80 | ||
Previous Close | $0.90 | ||
Volume | 60,305 | ||
30-Day Average Volume | 190,116 | ||
1-Week Change | 8.55% | ||
1-Month Change | 6.19% | ||
1-Year Change | -44.29% | ||
3-Year Change | -71.15% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 10.9M | ||
Total Assets | $8.0M | ||
Market Cap | $11.3M | ||
Enterprise Value | $9.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue